Bio Solution Co.,Ltd. (KOSDAQ:086820)

Bio Solution Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2020	FY 2019
Period Ending	Mar 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	8,275	7,744	8,882
Other Revenue	-0	-	0
Revenue	8,275	7,744	8,882
Revenue Growth (YoY)	-6.84%	-12.81%	-
Cost of Revenue	3,573	3,498	3,033
Gross Profit	4,702	4,246	5,850
Selling, General & Admin	3,453	3,541	3,436
Research & Development	3,208	3,230	3,645
Other Operating Expenses	149.13	147.87	137.2
Operating Expenses	7,499	7,576	7,717
Operating Income	-2,797	-3,330	-1,868
Interest Expense	-47.28	-40.48	-52.6
Interest & Investment Income	1,452	1,427	859.13
Currency Exchange Gain (Loss)	-3.38	-15.13	4.03
Other Non Operating Income (Expenses)	42.76	55.51	12.08
EBT Excluding Unusual Items	-1,353	-1,903	-1,045
Gain (Loss) on Sale of Investments	65.77	103.52	347.5
Pretax Income	-1,283	-1,800	-697.54
Net Income	-1,283	-1,800	-697.54
Net Income to Common	-1,283	-1,800	-697.54
Shares Outstanding (Basic)	8	8	8
Shares Outstanding (Diluted)	8	8	8
Shares Change (YoY)	1.40%	1.29%	-
EPS (Basic)	-160.90	-225.99	-88.72
EPS (Diluted)	-161.07	-226.00	-89.00
Free Cash Flow	-1,660	-3,077	-4,785
Free Cash Flow Per Share	-208.22	-386.38	-608.62
Gross Margin	56.82%	54.83%	65.86%
Operating Margin	-33.80%	-43.00%	-21.03%
Profit Margin	-15.50%	-23.24%	-7.85%
Free Cash Flow Margin	-20.06%	-39.73%	-53.87%
EBITDA	-964.75	-1,529	-331.19
EBITDA Margin	-11.66%	-19.75%	-3.73%
D&A For EBITDA	1,833	1,800	1,536
EBIT	-2,797	-3,330	-1,868
EBIT Margin	-33.80%	-43.00%	-21.03%
Advertising Expenses	-	119.42	89.35

Updated May 17, 2021. Source: S&P Global Market Intelligence. Standard template. Financial Sources.